Dec 28, 2020
1:16
For every 16 shares held, investors received 1. The price per share adjusted from $0.90 to $0.06.
The split itself did not change the total investment value.
Zevra Therapeutics, Inc. (ZVRA) trades on the NASDAQ Global Select in the Biotechnology industry.
Zevra Therapeutics, Inc. company overviewThe latest split shown was on December 28, 2020. It was a 1-for-16 reverse split, so shareholders received 1 share for every 16 they held.
This history records one reverse split, on December 28, 2020.